We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.40 | 0.75% | 188.00 | 187.60 | 188.20 | 188.00 | 185.20 | 187.40 | 72,417 | 11:55:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 25.68 | 408.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/2/2019 07:41 | Acquisition of Sealantis commented upon in The Jerusalem Post - worth reading: Part: Sealantis develops medical-device products for a variety of applications in surgical adhesion, mimicking the mechanism of adhesion of algae to rocks in water. The company was established under the leadership of Technion’s Prof. Havazelet Bianco-Peled, an expert in biomedical polymers. “The journey of Sealantis is underway. The merger into AMS is an important milestone in the realization of our vision – to enable medical teams around the world to prevent serious surgical complications thanks to Sealantis’s products,” said CEO Tomer Fuchs. “Following the merger, AMS will enjoy our scientific and engineering capabilities as an Israeli start-up company in the field of biotechnology, which includes innovation and the ability to bring simple and original solutions to complex challenges. AMS plans to expand operations in Israel, enabling it to expand into new, significant directions.” Sealantis’s current focus is on surgical seals designed for a variety of applications such as stopping bleeding, preventing leakage of digestive tract contents into the abdominal cavity and preventing leakage of spinal fluid. | mirandaj | |
31/1/2019 14:32 | You cannot say that AMS are sitting back on their success i.e. money in the Bank. The potential for growth is considerable with this acquisition and the Market loves growth. IMHO AMS must be looking more and more attractive to a bigger predator. | dealit | |
31/1/2019 12:45 | Interesting insight into Sealantis given by Tomer Fuchs on youtube. Also more details on their website sealantis.co.il | potty punter | |
31/1/2019 08:14 | winnings What is the multiple that they are paying? In $ £ or Israeli widgets? | redartbmud | |
31/1/2019 08:09 | Today's RNS is what many shareholders have been waiting for. Good to see AMS putting its excessive cash pile to good use. | winnings1 | |
31/1/2019 08:01 | Winsford, UK, 31 January 2019: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, today announces it has acquired Sealantis Limited ("Sealantis"), a developer of an alginate-based tissue adhesive technology platform, for $US 25m (approximately £19m) in cash with royalties due until December 2027 on sales of any of its products that are currently in development. Commenting on the acquisition, Chris Meredith, CEO of AMS, said: "This acquisition is in line with our strategy to acquire technologies that are complementary to our surgical portfolio as well as allowing us to leverage our global routes to market. The acquisition enhances our access to a significant and high-margin market in internal surgery, which includes areas of unmet need for effective and absorbable internal sealants, a market estimated at $1 billion. We are particularly excited to welcome Sealantis' innovation team of R&D experts to AMS and look forward to working alongside them to develop the technology in a wide range of potential applications and indications. As we work towards the commercialisation of Seal-G Surgical Sealant over the next 18 months, we expect to maximise the full value of the platform and this innovative technology. AMS continues to actively monitor and evaluate other acquisition opportunities to capitalise on its strong financial and strategic position." | dealit | |
25/1/2019 08:36 | Also weird how the share price drops/is dropped first thing, to recover later. | wetdream | |
23/1/2019 15:48 | Why does AMS share price move up and down on such small volume? | dealit | |
17/1/2019 09:52 | Got caught out by the Oct mkt collapse. Gutted that AMS was affected....🙄 Pleased to see that sanity's returning! | wetdream | |
16/1/2019 22:39 | so true WhiteBicycle I still have my whole holding of AMS from those days, but only 10% of my ASOS there were a few other picks that didn't do as well...... | malcontent | |
16/1/2019 22:19 | I'd like to think this company was Brexit proof. Manufacturing in Europe and the UK and selling and licensing into the USA. I hold 40% of my original holding on so called profesional advice. The ADVFN of 18years ago was a great place for investing in companies like this. Another one was Assos. | whitebicycle | |
16/1/2019 18:20 | I would like to think so `wetdream`. | dealit | |
16/1/2019 17:38 | Good news on the way? | wetdream | |
07/1/2019 17:23 | Good move up today on such small volume. | dealit | |
31/12/2018 08:07 | I have held for many years always believing that AMS would get taken over as they progressed I still hold that view. | dealit | |
31/12/2018 07:44 | It was about 18 years ago I was introduced to this Company at 4p ish. Never bought a single one. Don't think it's ever been diluted either. It's done well over the years. | gerryjames | |
31/12/2018 07:35 | i see it - Praise then -OK No probs - Just very odd wording Commenting on the announcement, Peter Allen, Non-Executive Chairman of AMS, said: "I would like to thank Mary for her 19 years of dedicated and outstanding service to AMS. In her time with the Group, she has been integral to our listing on AIM, several acquisitions and this has culminated in AMS growing for 13 consecutive years. At the same time, I would also like to congratulate Eddie on his forthcoming appointment as Chief Financial Officer and we look forward to welcoming him to the Board in due course." | pugugly | |
31/12/2018 07:33 | As per RNS it was announced on 6th June. | snape | |
31/12/2018 07:29 | Problems ?? Very abrupt notice - Winsford, UK, 31 December 2018: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, today announces with immediate effect the retirement of Mary Tavener from the role of Chief Financial Officer and Board Director, and confirms the appointment of Eddie Johnson, previously Group Financial Controller, as Chief Financial Officer and Board Director, with effect from 1 January 2019, per the Company's announcement dated 6 June 2018. | pugugly | |
24/12/2018 09:35 | That is olde hat | buywell3 | |
24/12/2018 07:59 | Donald Trump. Nigel Farage and Boris Johnson make great bed-mates. All three equally ignorant of the potential damaging consequences of their actions. All three rather fond of themselves. | winnings1 | |
24/12/2018 07:21 | Trump is just carrying on from our Politicians destabilising Europe. Have a good Xmas and new year "winning1". | dealit | |
24/12/2018 00:15 | Trump is destabilising the world, politically and economically. AMS will nonetheless continue to make good progress - wound care and surgical/medical innovations will not go out of fashion. | winnings1 | |
23/12/2018 15:38 | I don't know how low we may drop in the coming months of world wide uncertainty, cream always rises to the top. | dealit |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions